BTG Competitors and Similar CompaniesClear all

BTG's competitors and similar companies include Zogenix and Affimed N.V..
BTG
BTG
BTG is an international specialist healthcare company.
Zogenix
Zogenix
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
Affimed N.V.
Affimed N.V.
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
Founding Date
Founding Date
1948
Founding Date
2006
Founding Date
2000
Type
Type
Subsidiary
Type
Subsidiary
Type
Public
Tags
Locations
Locations
London, GB HQ
Rosedale, AU
Ottawa, CA
Düsseldorf, DE
Yokne'am Illit, IL
see more
Locations
Emeryville, US HQ
Maidenhead, GB
Locations
Heidelberg, DE HQ
Employees
Employees
6361% decrease
Employees
14157% increase
Employees
219
Twitter followers
Twitter followers
1.1 k
Twitter followers
2
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
£731.3m (FY, 2019)
Revenue (est.)
$81.7m (FY, 2021)
Revenue (est.)
€8.3m (FY, 2023)
Cost of goods
Cost of goods
£221m (FY, 2019)
Cost of goods
$4.8m (FY, 2021)
Cost of goods
N/A
Gross profit
Gross profit
£510.3m (FY, 2019)
Gross profit
N/A
Gross profit
€13m (FY, 2023)
Net income
Net income
£88.3m (FY, 2019)
Net income
($227.4m) (FY, 2021)
Net income
(€105.9m) (FY, 2023)
For sources of this data, please see the company profile

View Company Profiles

Zogenix
HQ
Emeryville, US

Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.

View company
Affimed N.V.
HQ
Heidelberg, DE
Employees
219

Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.

View company